SRx Global Inc

Aktienanalyse zu SRx Global Inc (SRXH)

$1.710

-0.039 (-2.29%)Zum Schluss

Loading chart…
High
1.780
Open
1.770
VWAP
1.73
Vol
597.23K
Mkt Cap
Low
1.706
Amount
1.03M
EV/EBITDA, TTM
0.00

SRx Global Inc. is an artificial intelligence (AI)-driven platform focused on investments in high-conviction operating companies, strategic assets, and technology-enabled opportunities. The Company leverages proprietary technology, data analytics, and disciplined capital allocation to identify and manage investments across multiple sectors. Its portfolio includes EMJX and Halo pets. EMJX is a digital-asset treasury platform designed as a treasury operating system, applying models, artificial intelligence, and systematic risk controls to multi-asset digital treasury management. Halo pets is engaged in selling premium pet products for dogs and cats. Halo pets offer Dry Food, Freeze-Dried Raw, Wet Food, Toppers, Dental, Treats & Chews, and others. Its dry food includes Freeze-Dried Raw Beef Meal Bites 14 oz, Freeze-Dried Raw Turkey Meal Bites 14 oz, Holistic Vegan Plant-Based with Superfoods Recipe Adult Dry Dog Food, and others.

AI analysis of SRx Global Inc (SRXH)

buy

SRx Health Solutions Inc (SRXH) appears to be a good buy right now due to its recent compliance with NYSE standards, which is likely to enhance investor confidence and liquidity. The stock is currently priced at 1.71, with a significant potential upside indicated by a projected final change of +152.55% based on historical patterns. However, it is important to note that the stock has experienced a year-to-date change of -88.02%, indicating substantial volatility and risk.

Bewertungskennzahlen

The current forward P/E ratio for SRx Global Inc (SRXH) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
Überbewertet
0.00
Unterbewertet
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Überbewertet
0.00
Unterbewertet
0.00

Forward P/S

Strongly Undervalued
5Y Average P/S
0.00
Current P/S
0.00
Überbewertet
0.00
Unterbewertet
0.00

Alphio AI Price Scenarios for SRXH

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%SRXH

$0.65

Szenariopreis

B

Base

Base · 50%SRXH

$0.61

Szenariopreis

B

Bear

Bear · 25%SRXH

$0.58

Szenariopreis

Event-Zeitleiste

2026-08-04 (ET)

05:30:00

SRX Global Acquires Stake in Vistagen

2026-07-30 (ET)

14:30:00

SRX Global Acquires Shares in Jersey Mike's IPO

2026-07-09 (ET)

12:00:00

SRX Global Authorizes Repurchase of Up to 10M Shares

12:00:00

SRx Global Inc Trading Halted, News Pending

2026-07-08 (ET)

14:00:00

SRX Global Updates Balance Sheet Metrics and Capital Structure

News

SRXH FAQ — answered by Alphio AI

SRx Global Inc. is an artificial intelligence (AI)-driven platform focused on investments in high-conviction operating companies, strategic assets, and technology-enabled opportunities. The Company leverages proprietary technology, data analytics, and disciplined capital allocation to identify and manage investments across multiple sectors. Its portfolio includes EMJX and Halo pets. EMJX is a digital-asset treasury platform designed as a treasury operating system, applying models, artificial intelligence, and systematic risk controls to multi-asset digital treasury management. Halo pets is engaged in selling premium pet products for dogs and cats. Halo pets offer Dry Food, Freeze-Dried Raw, Wet Food, Toppers, Dental, Treats & Chews, and others. Its dry food includes Freeze-Dried Raw Beef Meal Bites 14 oz, Freeze-Dried Raw Turkey Meal Bites 14 oz, Holistic Vegan Plant-Based with Superfoods Recipe Adult Dry Dog Food, and others. It operates in the Technology sector.

SRx Health Solutions Inc (SRXH) appears to be a good buy right now due to its recent compliance with NYSE standards, which is likely to enhance investor confidence and liquidity. The stock is currently priced at 1.71, with a significant potential upside indicated by a projected final change of +152.55% based on historical patterns. However, it is important to note that the stock has experienced a year-to-date change of -88.02%, indicating substantial volatility and risk.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten